LK
Lakefront Biotherapeutics N.V.
LKFT · NASDAQ
$28.55 -0.76% (-$0.22)
1M -1.69%
Market Cap 1.64B €
P/E Ratio 2.75x
Div. Yield -
ROE 19.58%
Bulios Fair Price
$29.36
2.8% upside
Trenutna cena
$28.55
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica LKFT trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
98 /100
Cheap EV/EBITDA 2.84x
P/S 1.65x
P/B 0.50x
Growth
7 /100
Declining Book val. growth 1.54%
Rev. growth 20.55%
FCF growth N/A
Profitability
70 /100
Strong Net margin 60.23%
Op. margin 61.57%
FCF margin 19.93%
Quality
86 /100
Excellent ROE 19.58%
ROA 17.81%
Asset turnover 0.30x
Debt
100 /100
Low Current ratio 32.82x
Int. coverage 1,886.14x
Net debt/EBITDA -0.24x
Stability
18 /100
Unstable Rev. volatility 29.25%
EPS volatility 90.33%
Profitable years 3
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LKFT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry O. Gosebruch
Employees
452
Headquarters
Mechelen
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report